WVU in the News: Improved medical screening in PFAS-impacted communities to identify early disease
When people learn they are exposed to toxic chemicals, they wonder what it means for their health and often want to take protective action.
Medical screening is the testing for early signs of disease. For people who have elevated exposure to PFAS, screening for conditions associated with PFAS exposure may allow for early identification of indicators of disease.
"Medical screening is designed for earlier detection of disease, including biomarkers of disease processes, that can lead to earlier intervention and diminish the effects of exposure," Dr. Alan Ducatman, a physician, PFAS expert, and retired professor of occupational medicine, said.